News Image

Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV

Provided By GlobeNewswire

Last update: Jun 9, 2025

National TV Segment Highlights FDA-Approved Treatment for Rosacea

Segment premiered on Monday, June 9 and will be rebroadcast on Thursday, June 19, at 7:30 a.m. PT/ ET

Read more at globenewswire.com

FORTRESS BIOTECH INC

NASDAQ:FBIO (8/15/2025, 8:18:30 PM)

After market: 2.17 +0.05 (+2.36%)

2.12

+0.16 (+8.16%)


JOURNEY MEDICAL CORP

NASDAQ:DERM (8/15/2025, 8:15:37 PM)

After market: 6.3259 -0.62 (-8.98%)

6.95

-0.31 (-4.27%)



Find more stocks in the Stock Screener

Follow ChartMill for more